Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN
Overview of attention for article published in Blood, August 2017
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Mentioned by
- policy
- 1 policy source
- 38 X users
- patent
- 2 patents
- 1 Facebook page
- googleplus
- 1 Google+ user
Readers on
- mendeley
- 150 Mendeley